Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-29T10:56:57.611Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis

Published online by Cambridge University Press:  06 May 2010

J. Guidi ,
G. A. Fava ,
M. Fava  and
G. I. Papakostas
J. Guidi*
Affiliation:
Affective Disorders Program, Department of Psychology, University of Bologna, Italy
G. A. Fava
Affiliation:
Affective Disorders Program, Department of Psychology, University of Bologna, Italy Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA
M. Fava
Affiliation:
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA Department of Psychiatry, Harvard Medical School, Boston, MA, USA
G. I. Papakostas
Affiliation:
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA Department of Psychiatry, Harvard Medical School, Boston, MA, USA
*
*Address for correspondence: J. Guidi, Psy.D., Department of Psychology, University of Bologna, Viale Berti Pichat, 5, 40127 Bologna, Italy. (Email: jenny.guidi2@unibo.it)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Prevention of relapse and recurrence represents an important task in the successful treatment of major depressive disorder (MDD). The aim of this meta-analysis was to examine the efficacy of the sequential integration of psychotherapy and pharmacotherapy in reducing the risk of relapse and recurrence in MDD.

Method

Keyword searches were conducted in Medline, EMBASE, PsycINFO and the Cochrane Library from inception of each database to December 2008. Randomized controlled trials examining the efficacy of the administration of psychotherapy after successful response to acute-phase pharmacotherapy in the treatment of adults with MDD were considered for inclusion in the meta-analysis.

Results

Eight high-quality studies with 442 patients in a sequential treatment arm and 433 in a control treatment arm were included. The pooled risk ratio (RR) for relapse/recurrence was 0.797 [95% confidence interval (CI) 0.659–0.964] according to the random-effects model, suggesting a relative advantage in preventing relapse/recurrence for the sequential administration of treatments compared with control conditions. Performing subgroup analyses, we found a trend favoring psychotherapy during continuation of antidepressant drugs compared to antidepressants or treatment as usual (RR 0.842, 95% CI 0.674–1.051). Patients randomized to psychotherapy while antidepressants were discontinued were significantly less likely to experience relapse/recurrence compared to controls (RR 0.650, 95% CI 0.463–0.912).

Conclusions

We found evidence that the sequential integration of psychotherapy and pharmacotherapy is a viable strategy for preventing relapse and recurrence in MDD. In addition, our findings suggest that discontinuation of antidepressant drugs may be feasible when psychotherapy is provided.

Keywords

Major depressive disordermeta-analysispsychotherapyrecurrencesequential treatment
Type
Original Articles
Information
Psychological Medicine , Volume 41 , Issue 2 , February 2011 , pp. 321 - 331
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barnhofer, T, Duggan, D, Crane, C, Hepburn, S, Fennell, MJV, Williams, JMG (2007). Effects of meditation on frontal α-asymmetry in previously suicidal individuals. Neuroreport 18, 709–712.CrossRefGoogle ScholarPubMed
Bech, P (2009). Fifty years with the Hamilton scales for anxiety and depression. Psychotherapy and Psychosomatics 78, 202–211.CrossRefGoogle ScholarPubMed
Begg, C (1994). Publication bias. In The Handbook of Research Synthesis (ed. Cooper, H. and Hedges, L. V.), pp. 399–409. Russell Sage Foundation: New York.Google Scholar
Blackburn, IM, Bishop, S, Glen, AIM, Whalley, LJ, Christie, JE (1981). The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry 139, 181–189.CrossRefGoogle ScholarPubMed
Blackburn, IM, Eunson, KM, Bishop, S (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders 10, 67–75.CrossRefGoogle Scholar
Blackburn, IM, Moore, RG (1997). Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. British Journal of Psychiatry 171, 328–334.CrossRefGoogle ScholarPubMed
Bockting, CLH, Schene, AH, Spinhoven, P, Koeter, MWJ, Wouters, LF, Huyser, J, Kamphuis, JH (2005). Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. Journal of Consulting and Clinical Psychology 73, 647–657.CrossRefGoogle ScholarPubMed
Bockting, CLH, Spinhoven, P, Koeter, MWJ, Wouters, LF, Schene, AH (2006). Prediction of recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study. Journal of Clinical Psychiatry 67, 747–755.CrossRefGoogle ScholarPubMed
Bockting, CLH, ten Doesschate, MC, Spijker, J, Spinhoven, P, Koeter, MWJ, Schene, AH (2008). Continuation and maintenance use of antidepressants in recurrent depression. Psychotherapy and Psychosomatics 77, 17–26.CrossRefGoogle ScholarPubMed
Cochran, WG (1954). The combination of estimates from different experiments. Biometrics 10, 101–129.CrossRefGoogle Scholar
de Maat, S, Dekker, J, Schoevers, R, van Aalst, G, Gijsbers-van Wijk, G, Hendriksen, M, Kool, S, Peen, J, Van, R, de Jonghe, F (2008). Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials. Depression and Anxiety 25, 565–574.CrossRefGoogle ScholarPubMed
Depression Guideline Panel (1993). Clinical Practice Guideline Number 5: Depression in Primary Care. Volume 1: Detection and Diagnosis. AHCR publication 93-0550. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research: Rockville, MD.Google Scholar
Egger, M, Davey-Smith, G, Schneider, M, Minder, C (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315, 629–634.CrossRefGoogle ScholarPubMed
Fabbri, S, Fava, GA, Rafanelli, C, Tomba, E (2007). Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. Journal of Clinical Psychiatry 68, 1348–1351.CrossRefGoogle ScholarPubMed
Fava, GA (1999). Subclinical symptoms in mood disorders. Psychological Medicine 29, 47–61.CrossRefGoogle ScholarPubMed
Fava, GA, Grandi, S, Rafanelli, C, Ruini, C, Conti, S, Belluardo, P (2001 a). Long-term outcome of social phobia treated by exposure. Psychological Medicine 31, 899–905.CrossRefGoogle ScholarPubMed
Fava, GA, Grandi, S, Zielezny, M, Canestrari, R, Morphy, MA (1994). Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. American Journal of Psychiatry 151, 1295–1299.Google ScholarPubMed
Fava, GA, Grandi, S, Zielezny, M, Rafanelli, C, Canestrari, R (1996). Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry 153, 945–947.Google ScholarPubMed
Fava, GA, Kellner, R (1991). Prodromal symptoms in affective disorder. American Journal of Psychiatry 148, 823–830.Google Scholar
Fava, GA, Rafanelli, C, Cazzaro, M, Conti, S, Grandi, S (1998 a). Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychological Medicine 28, 475–480.CrossRefGoogle ScholarPubMed
Fava, GA, Rafanelli, C, Grandi, S, Canestrari, R, Morphy, M (1998 b). Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry 155, 1443–1445.CrossRefGoogle ScholarPubMed
Fava, GA, Rafanelli, C, Grandi, S, Conti, S, Belluardo, P (1998 c). Prevention of recurrent depression with cognitive behavioral therapy. Archives of General Psychiatry 55, 816–820.CrossRefGoogle ScholarPubMed
Fava, GA, Rafanelli, C, Grandi, S, Conti, S, Belluardo, P (1999). The role of residual subthreshold symptoms in early episode relapse in unipolar depressive disorder. Archives of General Psychiatry 56, 764–765.Google Scholar
Fava, GA, Rafanelli, C, Grandi, S, Conti, S, Ruini, C, Mangelli, L, Belluardo, P (2001 b). Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychological Medicine 31, 891–898.CrossRefGoogle ScholarPubMed
Fava, GA, Ruini, C, Rafanelli, C (2005 a). Sequential treatment of mood and anxiety disorders. Journal of Clinical Psychiatry 66, 1392–1400.CrossRefGoogle ScholarPubMed
Fava, GA, Ruini, C, Rafanelli, C, Finos, L, Conti, S, Grandi, S (2004). Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. American Journal of Psychiatry 161, 1872–1876.CrossRefGoogle ScholarPubMed
Fava, GA, Ruini, C, Rafanelli, C, Finos, L, Salmaso, L, Mangelli, L, Sirigatti, S (2005 b). Well-being therapy of generalized anxiety disorder. Psychotherapy and Psychosomatics 74, 26–30.CrossRefGoogle ScholarPubMed
Fava, GA, Ruini, C, Rafanelli, C, Grandi, S (2002). Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. American Journal of Psychiatry 159, 2094–2095.CrossRefGoogle ScholarPubMed
Fava, GA, Ruini, C, Sonino, N (2003). Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs 17, 1109–1117.CrossRefGoogle ScholarPubMed
Fava, GA, Tomba, E, Grandi, S (2007). The road to recovery from depression. Don't drive today with yesterday's map. Psychotherapy and Psychosomatics 76, 260–265.CrossRefGoogle ScholarPubMed
Frank, E, Grochocinski, VJ, Spanier, CA, Buysse, DJ, Cherry, CR, Houck, PR, Stapf, DM, Kupfer, DJ (2000). Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression. Journal of Clinical Psychiatry 61, 51–57.CrossRefGoogle ScholarPubMed
Frank, E, Kupfer, DJ, Perel, JM, Cornes, C, Jarrett, RB, Mallinger, AG, Thase, ME, McEachran, AB, Grochocinski, VJ (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 47, 1093–1099.CrossRefGoogle ScholarPubMed
Gaynes, BN, Magruder, KM, Burns, BJ, Wagner, HR, Yarnall, KSH, Broadhead, WE (1999). Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? General Hospital Psychiatry 21, 158–167.CrossRefGoogle ScholarPubMed
Higgins, JPT, Thompson, SG (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 1539–1558.CrossRefGoogle ScholarPubMed
Jarrett, RB, Basco, MR, Risser, R, Ramanan, J, Marwill, M, Kraft, D, Rush, AJ (1998). Is there a role for continuation phase cognitive therapy for depressed outpatients? Journal of Consulting and Clinical Psychology 66, 1036–1040.CrossRefGoogle Scholar
Jarrett, RB, Kraft, D, Doyle, J, Foster, BM, Eaves, GG, Silver, PC (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase. Archives of General Psychiatry 58, 381–388.CrossRefGoogle ScholarPubMed
Jarrett, RB, Kraft, D, Schaffer, M, Witt-Browder, A, Risser, R, Atkins, DH, Doyle, J (2000). Reducing relapse in depressed outpatients with atypical features: a pilot study. Psychotherapy and Psychosomatics 69, 232–239.CrossRefGoogle ScholarPubMed
Judd, LJ, Paulus, MJ, Schettler, PJ, Akiskal, HS, Endicott, J, Leon, AC, Maser, JD, Mueller, T, Solomon, DA, Keller, MB (2000). Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry 157, 1501–1504.CrossRefGoogle Scholar
Keller, MB, McCullough, JP, Klein, DN, Arnow, B, Dunner, DL, Gelenberg, AJ, Markowitz, JC, Nemeroff, CB, Russell, JM, Thase, ME, Trivedi, MH, Zajecka, J (2000). A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342, 1462–1470.CrossRefGoogle ScholarPubMed
Kingston, T, Dooley, B, Bates, A, Lawlor, E, Malone, K (2007). Mindfulness-based cognitive therapy for residual depressive symptoms. Psychology and Psychotherapy: Theory, Research and Practice 80, 193–203.CrossRefGoogle ScholarPubMed
Klein, DN, Santiago, NJ, Vivian, D, Blalock, JA, Kocsis, JH, Markowitz, JC, Cullough, JP Jr., Rush, AJ, Trivedi, MH, Arnow, BA, Dunner, DL, Manber, R, Rothbaum, B, Thase, ME, Keitner, GI, Miller, IW, Keller, MB (2004). Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology 72, 681–688.CrossRefGoogle ScholarPubMed
Klerman, GL, DiMascio, A, Weissman, M, Prusoff, B, Paykel, ES (1974). Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry 131, 186–191.CrossRefGoogle ScholarPubMed
Kühner, C (2005). An evaluation of the Coping with Depression Course for relapse prevention with unipolar depressed patients. Psychotherapy and Psychosomatics 74, 254–259.CrossRefGoogle Scholar
Kühner, C, Angermayer, MC, Veiel, HO (1996). Cognitive-behavioral group intervention as a means of tertiary prevention in depressed patients: acceptance and short-term efficacy. Cognitive Therapy and Research 20, 391–409.CrossRefGoogle Scholar
Kupfer, DJ (1992). Maintenance treatment in recurrent depression. British Journal of Psychiatry 161, 309–316.CrossRefGoogle ScholarPubMed
Kuyken, W, Byford, S, Taylor, RS, Watkins, E, Holden, E, White, K, Barrett, B, Byng, R, Evans, A, Mullan, E, Teasdale, JD (2008). Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. Journal of Consulting and Clinical Psychology 76, 966–978.CrossRefGoogle ScholarPubMed
Ma, SH, Teasdale, JD (2004). Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 72, 31–40.CrossRefGoogle ScholarPubMed
Maj, M (2005). The aftermath of the concept of psychiatric comorbidity. Psychotherapy and Psychosomatics 74, 67–68.CrossRefGoogle ScholarPubMed
Marks, I (2009). Mental health clinics in the 21st century. Psychotherapy and Psychosomatics 78, 133–138.CrossRefGoogle Scholar
Miller, L, Weissman, M (2002). Interpersonal psychotherapy delivered over telephone to recurrent depressives: a pilot study. Depression and Anxiety 16, 114–117.CrossRefGoogle ScholarPubMed
Mohr, DC, Spring, B, Freedland, KE, Beckner, V, Arean, P, Hollon, SD, Ockene, J, Kaplan, R (2009). The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics 78, 275–284.CrossRefGoogle ScholarPubMed
Morin, CM, Vallières, A, Guay, B, Ivers, H, Savard, J, Mérette, C, Bastien, C, Baillargeon, L (2009). Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. Journal of the American Medical Association 301, 2005–2015.CrossRefGoogle ScholarPubMed
Pampallona, S, Bollini, P, Tibaldi, G, Kupelnick, B, Munizza, C (2004). Combined pharmacotherapy and psychological treatment of depression: a systematic review. Archives of General Psychiatry 61, 714–719.CrossRefGoogle ScholarPubMed
Pava, JA, Fava, M, Levenson, JA (1994). Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression. Psychotherapy and Psychosomatics 61, 211–219.CrossRefGoogle ScholarPubMed
Paykel, ES, Ramana, R, Cooper, Z, Hayhurst, H, Kerr, J, Barocka, A (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine 25, 1171–1180.CrossRefGoogle ScholarPubMed
Paykel, ES, Scott, J, Cornwall, PL, Abbott, C, Crane, C, Pope, M, Johnson, AL (2005). Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychological Medicine 35, 59–68.CrossRefGoogle ScholarPubMed
Paykel, ES, Scott, J, Teasdale, JD, Johnson, AL, Garland, A, Moore, R, Jenaway, A, Cornwall, PL, Hayhurst, H, Abbot, R, Pope, M (1999). Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry 56, 829–835.CrossRefGoogle ScholarPubMed
Perlis, RH, Nierenberg, AA, Alpert, JE, Pava, J, Matthews, JD, Buchin, J, Sickinger, AH, Fava, M (2002). Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology 22, 474–480.CrossRefGoogle ScholarPubMed
Petersen, T, Harley, R, Papakostas, GI, Montoya, HD, Fava, M, Alpert, JE (2004). Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychological Medicine 34, 555–561.CrossRefGoogle ScholarPubMed
Pincus, HA, Tew, JD, First, MB (2004). Psychiatric comorbidity: is more less? World Psychiatry 3, 18–23.Google ScholarPubMed
Rafanelli, C, Park, SK, Fava, GA (1999). New psychotherapeutic approaches to residual symptoms and relapse prevention in unipolar depression. Clinical Psychology and Psychotherapy 6, 194–201.3.0.CO;2-L>CrossRefGoogle Scholar
Reynolds, CF III, Dew, MA, Pollock, BG, Mulsant, BH, Frank, E, Miller, MD, Houck, PR, Mazumdar, S, Butters, MA, Stack, JA, Schlernitzauer, MA, Whyte, EM, Gildengers, A, Karp, J, Lenze, E, Szanto, K, Bensasi, S, Kupfer, DJ (2006). Maintenance treatment of major depression in old age. New England Journal of Medicine 354, 1130–1138.CrossRefGoogle ScholarPubMed
Reynolds, CF III, Frank, E, Perel, JM, Imber, SD, Cornes, C, Miller, MD, Mazumdar, S, Houck, PR, Dew, MA, Stack, JA, Pollock, BG, Kupfer, DJ (1999). Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. Journal of the American Medical Association 281, 39–45.CrossRefGoogle ScholarPubMed
Scott, J, Colom, F, Vieta, E (2007). A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. International Journal of Neuropsychopharmacology 10, 123–129.CrossRefGoogle ScholarPubMed
Scott, J, Palmer, S, Paykel, ES, Teasdale, J, Hayhurst, H (2003). Use of cognitive therapy for relapse prevention in chronic depression: cost-effectiveness study. British Journal of Psychiatry 182, 221–227.CrossRefGoogle ScholarPubMed
Scott, J, Teasdale, JD, Paykel, ES, Johnson, AL, Abbott, R, Hayhurst, H, Moore, R, Garland, A (2000). Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry 177, 440–446.CrossRefGoogle ScholarPubMed
Segal, ZV, Pearson, JL, Thase, ME (2003). Challenges in preventing relapse in major depression: report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression. Journal of Affective Disorders 77, 97–108.CrossRefGoogle ScholarPubMed
Sherbourne, CD, Wells, KB (1997). Course of depression in patients with comorbid anxiety disorders. Journal of Affective Disorders 43, 245–250.CrossRefGoogle ScholarPubMed
Teasdale, JD, Moore, RG, Hayhurst, H, Pope, M, Williams, S, Segal, ZV (2002). Metacognitive awareness and prevention of relapse in depression: empirical evidence. Journal of Consulting and Clinical Psychology 70, 275–287.CrossRefGoogle ScholarPubMed
Teasdale, JD, Segal, ZV, Williams, JMG, Ridgeway, VA, Soulsby, JM, Lau, MA (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 68, 615–623.CrossRefGoogle ScholarPubMed
Vallières, A, Morin, CM, Guay, B (2005). Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. Behaviour Research and Therapy 43, 1611–1630.CrossRefGoogle ScholarPubMed
Vittengl, JR, Clark, LA, Dunn, TW, Jarrett, RB (2007). Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. Journal of Consulting and Clinical Psychology 75, 475–488.CrossRefGoogle ScholarPubMed
Williams, JMG, Alatiq, Y, Crane, C, Barnhofer, T, Fennell, MJV, Duggan, DS, Hepburn, S, Goodwin, GM (2008). Mindfulness-based cognitive therapy in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. Journal of Affective Disorders 107, 275–279.CrossRefGoogle ScholarPubMed
Williams, JMG, Teasdale, JD, Segal, ZV, Soulsby, J (2000). Mindfulness-based cognitive therapy reduces overgeneral autobiographical memory in formerly depressed patients. Journal of Abnormal Psychology 109, 150–155.CrossRefGoogle ScholarPubMed
Zimmerman, M, Chelminski, I, McDermut, W (2002). Major depressive disorder and Axis I diagnostic comorbidity. Journal of Clinical Psychiatry 63, 187–193.CrossRefGoogle ScholarPubMed